treatment options

2025 guideline update to acute treatment of migraine for adults in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies

Study Overview This comprehensive review focuses on the advances in the management of acute migraine episodes in adults, specifically within

2025 guideline update to acute treatment of migraine for adults in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies Read Post »

Efficacy and safety of mirikizumab in paediatric participants with moderately-to-severely active ulcerative colitis (SHINE-1): a multicentre, open-label, non-randomised phase 2 trial

Study Overview The study aimed to evaluate the effectiveness and safety of mirikizumab, a monoclonal antibody targeting the IL-23 pathway,

Efficacy and safety of mirikizumab in paediatric participants with moderately-to-severely active ulcerative colitis (SHINE-1): a multicentre, open-label, non-randomised phase 2 trial Read Post »

Scroll to Top